Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David R. Jones, M.D.
Diffusion Pharmaceuticals Inc
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph'S Medical Center Barrow Neurology Clinics
Phoenix, Arizona, United States
- University of Arkansas Winthrop P. Rockefeller Cancer Institute
Little Rock, Arkansas, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- the George Washington University Medical Center
Washington D.C., District of Columbia, United States
- University of Florida Mcknight Brain Institute
Gainesville, Florida, United States
- Emory University Winship Cancer Institute
Atlanta, Georgia, United States
- Northwestern University Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Kentucky Markey Cancer Center
Lexington, Kentucky, United States
- North Shore University Hospital
Manhasset, New York, United States
- Forsyth Regional Cancer Center
Winston-Salem, North Carolina, United States
- Penn State University Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Baylor University Medical Center
Dallas, Texas, United States
- University of Texas Health Science Center Memorial Hermann Medical Center
Houston, Texas, United States
- Uva Health Sciences Center Emily Couric Clinical Cancer Center
Charlottesville, Virginia, United States
- Froedtert & Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2012
- Primary completion
- 30 Nov 2015
- Completion
- 29 Feb 2016
- Last update posted
- 14 Jul 2017
- Registered enrollment
- 59
- Registry id
- NCT01465347
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.